Re: Pierre Letourneau, Lara Cabezas, Aurélie De Mul, et al. Optimizing Screening Performance for the Risk of Hyperoxaluria and Urolithiasis Using the Urinary Oxalate/Creatinine Ratio: A Retrospective Analysis. Eur Urol Open Sci 2025;75:20-8. [PDF]
Liu D, Guan Z, Du Y.
europepmc +1 more source
Kidney Stone Events and ESKD Incidence in Patients with Enteric Hyperoxaluria from Diverse Enteric Etiologies. [PDF]
Tatton RW +5 more
europepmc +1 more source
Chronic leg ulcers in a patient with Hyperoxaluria type 1: a rare and challenging diagnosis. [PDF]
Kabbou S, Eljouari O, Gallouj S.
europepmc +1 more source
Primary Hyperoxaluria Type 2 Masquerading as Chronic Kidney Disease of Unknown Origin in an Adolescent: A Case Report. [PDF]
Garg M +4 more
europepmc +1 more source
Hydrogen Sulfide Deficiency Contributes to Tubular Damage and Calcium Oxalate Crystal Formation in Hyperoxaluria Nephropathy: Role of Osteopontin and Tamm-Horsfall Protein. [PDF]
Lu CL, Tseng YS, Wu WB, Liao CH, Ma MC.
europepmc +1 more source
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]
Deesker LJ +9 more
europepmc +1 more source
Recurrent vomiting in a 12-year old boy with diagnostic suspicion of hyperoxaluria : a case report [PDF]
Dossche, Lien +4 more
core +1 more source
CaSR regulates SLC26A6 expression via the PKA-FOXO4 signaling axis to promote experimental calcium oxalate kidney stone formation in rats. [PDF]
Gan L +8 more
europepmc +1 more source
Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate. [PDF]
Van de Perre E +14 more
europepmc +1 more source

